Tower Research Capital LLC (Trc) Coll Plant Biotechnologies LTD Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1 shares of CLGN stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$4% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
1.95MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD564KShares$2.8 Million0.05% of portfolio
-
Investment Management Of Virginia LLC464KShares$2.31 Million0.63% of portfolio
-
Villere St Denis J & CO LLC390KShares$1.94 Million0.17% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$1.37 Million2.69% of portfolio
-
Brown Advisory Inc119KShares$593,7410.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $55.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...